Kenneth Inglima
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- SARS-CoV-2 detection and testing 4
- COVID-19 Clinical Research Studies 4
- Antimicrobial Resistance in Staphylococcus 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Respiratory viral infections research 2
- Co-authors
- Maria E. Aguero‐Rosenfeld (9 shared papers)Philip M. Tierno (2 shared papers)Luke Tysall (1 shared paper)Neil Woodford (1 shared paper)Ronald E. Painter (1 shared paper)Marie-France I. Palepou (1 shared paper)Lynn L. Silver (1 shared paper)D L Shungu (1 shared paper)
- Journals
- Open Forum Infectious Diseases (5 papers)Journal of Experimental Biology (1 paper)Journal of Clinical Microbiology (1 paper)International Journal of Infectious Diseases (1 paper)Journal of Experimental Zoology (1 paper)
- Partner nations
- United States
In The Last Decade
Kenneth Inglima
19 papers receiving 900 citations
Peers
Comparison fields: 5 of 75
- Molecular Medicine 357
- Applied Microbiology and Biotechnology 60
- Endocrinology 125
- Clinical Biochemistry 140
- Infectious Diseases 362
Countries citing papers authored by Kenneth Inglima
This map shows the geographic impact of Kenneth Inglima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Inglima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Inglima more than expected).
Fields of papers citing papers by Kenneth Inglima
This network shows the impact of papers produced by Kenneth Inglima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Inglima. The network helps show where Kenneth Inglima may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth Inglima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 357 | |
| 2 | 2020 | 169 | |
| 3 | 2003 | 104 | |
| 4 | 2014 | 101 | |
| 5 | 1981 | 47 | |
| 6 | 2020 | 34 | |
| 7 | 2021 | 22 | |
| 8 | 2020 | 20 | |
| 9 | 2017 | 18 | |
| 10 | 1979 | 18 | |
| 11 | 1995 | 13 | |
| 12 | 2020 | 12 | |
| 13 | 2022 | 6 | |
| 14 | 2015 | 6 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 2 | |
| 17 | 2017 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2024 | 1 |
About Kenneth Inglima
Kenneth Inglima is a scholar working on Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Molecular Biology and Clinical Biochemistry, having authored 19 papers that have together received 936 indexed citations. Recurring topics across this work include SARS-CoV-2 detection and testing (4 papers), COVID-19 Clinical Research Studies (4 papers), Antibiotic Use and Resistance (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Respiratory viral infections research (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Fish biology, ecology, and behavior (1 paper). The work is most often cited by research in Molecular Medicine (357 citations), Applied Microbiology and Biotechnology (60 citations), Endocrinology (125 citations), Clinical Biochemistry (140 citations) and Infectious Diseases (362 citations). Kenneth Inglima has collaborated with scholars based in United States. Frequent co-authors include Maria E. Aguero‐Rosenfeld, Philip M. Tierno, Luke Tysall, Neil Woodford, Ronald E. Painter, Marie-France I. Palepou, Lynn L. Silver, D L Shungu, David M. Livermore and Robert Press. Their work appears in journals such as Open Forum Infectious Diseases, Journal of Experimental Biology, Journal of Clinical Microbiology, International Journal of Infectious Diseases and Journal of Experimental Zoology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.